You are here

  • Home
  • Archive
  • Volume 77, Issue Suppl 2
  • FRI0398 Sl-401, a novel targeted therapy directed to the interleukin-3 receptor (CD123), kills plasmacytoid dendritic cells from systemic sclerosispatients

Article metrics

Article menu

Download PDFPDF

FRIDAY, 15 JUNE 2018
Systemic sclerosis, myositis and related syndromes – etiology, pathogenesis and animal models
FRI0398 Sl-401, a novel targeted therapy directed to the interleukin-3 receptor (CD123), kills plasmacytoid dendritic cells from systemic sclerosispatients
Free

 

Online download statistics by month:

Online download statistics by month: June 2018 to August 2024

AbstractFullPdf
Jun 20182202
Jul 20183003
Aug 201864012
Sep 201852017
Oct 201860020
Nov 201816024
Dec 20183009
Jan 201954011
Feb 201910010
Mar 20193309
Apr 201929013
May 20192003
Jun 20192206
Jul 201936010
Aug 20191403
Sep 201912010
Oct 20191202
Nov 20191406
Dec 20192001
Jan 20201203
Feb 2020402
Mar 2020602
Apr 20201205
May 20201602
Jun 20201003
Jul 20201001
Aug 2020204
Sep 20202005
Oct 2020600
Nov 2020803
Dec 2020601
Jan 2021004
Feb 2021803
Mar 2021406
Apr 2021401
May 2021605
Jun 2021005
Jul 2021005
Aug 2021005
Sep 2021005
Oct 20216014
Nov 202110014
Dec 20211502
Jan 20221200
Feb 20221401
Mar 2022601
Apr 2022401
May 20221007
Jun 20221104
Jul 2022800
Aug 20221805
Sep 20221304
Oct 2022401
Nov 20221209
Dec 2022901
Jan 20231001
Feb 2023801
Mar 20231401
Apr 2023001
May 2023401
Jun 2023604
Jul 2023602
Aug 2023001
Sep 2023403
Oct 2023200
Nov 2023404
Dec 20231600
Jan 20241001
Feb 2024604
Mar 20245046
Apr 20245012
May 2024600
Jun 2024407
Jul 2024204
Aug 2024204
Total9500402